Gurugram based HealthTech startup Gabify has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures (IPV). The company has also received ₹25 lakh under the Nidhi Seed Support Scheme from GHRTBI. Gabify is developing an AI-powered SaaS platform for early detection and therapy management of speech and neurodevelopmental disorders such as autism and ADHD.
Glimpse:
The fresh capital will be used for clinical validation, technology development, and team expansion. The platform uses dual AI (voice + vision) to analyse speech patterns, facial expressions, eye gaze, and behavioural markers based on 189+ clinically validated parameters aligned with DSM-5 and CARS standards. It has been tested in over 35 preschool and daycare centres and aims to impact one million children by 2028.
Gabify, a Gurugram based HealthTech startup founded in 2023, has secured $175,000 in pre-seed funding led by Inflection Point Ventures (IPV). In addition, the company received a ₹25 lakh grant under the Nidhi Seed Support Scheme from GHRTBI. The funds will support further clinical validation, AI model enhancement, and team growth as Gabify scales its operations across India.
Gabify’s platform leverages dual artificial intelligence combining voice analysis for speech patterns and vision AI for facial expressions, eye tracking, and behavioural cues. It evaluates over 189 clinically validated parameters based on DSM-5 and CARS standards while maintaining a human in the loop approach for reliable clinical insights.
During its private beta phase, the solution was tested in more than 35 preschool and daycare centres. It is now being adopted by schools, hospitals, private clinics, and non-profit organisations. The platform can reportedly reduce assessment time by up to 70%, enabling clinicians to screen and support more children efficiently. It is designed to function effectively in low-bandwidth and multilingual settings, making it suitable for widespread use in diverse Indian communities.
The startup plans to expand through B2B, B2C, and CSR partnerships with the long term goal of reaching one million children by 2028. The global market for neurodevelopmental and assistive technologies is projected to reach $110 billion, driven by rising awareness and demand for early intervention.
“Gabify is building India’s first AI-powered platform for early screening and therapy management of speech and neurodevelopmental disorders.”
By
HB Team
